Catalyst Wire Dossier Catalyst Wire Dossier

emtricitabine/tenofovir disoproxil fumarate/elvitegravir/cobicistat

emtricitabine/tenofovir disoproxil fumarate/elvitegravir/cobicistat · Gilead Sciences
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for emtricitabine/tenofovir disoproxil fumarate/elvitegravir/cobicistat, covering 2016-03-10 to 2016-03-10. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of E/C/F/TDF Versus RTV-Boosted ATV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment-Naive Women [Phase 3]

See pricing